These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 36569877)
1. Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective review. Raghav A; Giri R; Agarwal S; Kala S; Jeong GB Front Immunol; 2022; 13():1040027. PubMed ID: 36569877 [TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19. Motallebnezhad M; Omraninava M; Esmaeili Gouvarchin Ghaleh H; Jonaidi-Jafari N; Hazrati A; Malekpour K; Bagheri Y; Izadi M; Ahmadi M Pathol Res Pract; 2023 Jan; 241():154280. PubMed ID: 36580795 [TBL] [Abstract][Full Text] [Related]
3. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2. Chen X; Li H; Song H; Wang J; Zhang X; Han P; Wang X J Extracell Vesicles; 2022 Dec; 11(12):e12288. PubMed ID: 36450704 [TBL] [Abstract][Full Text] [Related]
4. Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection. Fu Y; Xiong S J Control Release; 2021 Jul; 335():584-595. PubMed ID: 34089793 [TBL] [Abstract][Full Text] [Related]
5. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. Machhi J; Shahjin F; Das S; Patel M; Abdelmoaty MM; Cohen JD; Singh PA; Baldi A; Bajwa N; Kumar R; Vora LK; Patel TA; Oleynikov MD; Soni D; Yeapuri P; Mukadam I; Chakraborty R; Saksena CG; Herskovitz J; Hasan M; Oupicky D; Das S; Donnelly RF; Hettie KS; Chang L; Gendelman HE; Kevadiya BD J Neuroimmune Pharmacol; 2021 Jun; 16(2):270-288. PubMed ID: 33544324 [TBL] [Abstract][Full Text] [Related]
6. Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2. Park JH; Choi Y; Lim CW; Park JM; Yu SH; Kim Y; Han HJ; Kim CH; Song YS; Kim C; Yu SR; Oh EY; Lee SM; Moon J Cells; 2021 Sep; 10(9):. PubMed ID: 34572043 [TBL] [Abstract][Full Text] [Related]
7. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword? Xia X; Yuan P; Liu Y; Wang Y; Cao W; Zheng JC Immunology; 2021 Aug; 163(4):416-430. PubMed ID: 33742451 [TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients. Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P Front Immunol; 2023; 14():1052141. PubMed ID: 37251406 [TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update. Hernández-Díazcouder A; Díaz-Godínez C; Carrero JC Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2131-2141. PubMed ID: 36917275 [TBL] [Abstract][Full Text] [Related]
12. Acellular Human Amniotic Fluid-Derived Extracellular Vesicles as Novel Anti-Inflammatory Therapeutics against SARS-CoV-2 Infection. Chanda D; Del Rivero T; Ghimire R; More S; Mitrani MI; Bellio MA; Channappanavar R Viruses; 2024 Feb; 16(2):. PubMed ID: 38400048 [TBL] [Abstract][Full Text] [Related]
13. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089 [TBL] [Abstract][Full Text] [Related]
14. The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion. Chen TH; Tsai MJ; Chang CS; Xu L; Fu YS; Weng CF J Infect Public Health; 2023 Jan; 16(1):42-54. PubMed ID: 36470006 [TBL] [Abstract][Full Text] [Related]
15. The role of extracellular vesicles in COVID-19 virus infection. Hassanpour M; Rezaie J; Nouri M; Panahi Y Infect Genet Evol; 2020 Nov; 85():104422. PubMed ID: 32544615 [TBL] [Abstract][Full Text] [Related]
16. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection. Krishna G; Pillai VS; Veettil MV Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174 [TBL] [Abstract][Full Text] [Related]
17. Strong SARS-CoV-2 N-Specific CD8 Ferrantelli F; Chiozzini C; Manfredi F; Leone P; Spada M; Di Virgilio A; Giovannelli A; Sanchez M; Cara A; Michelini Z; Federico M Viruses; 2022 Feb; 14(2):. PubMed ID: 35215922 [TBL] [Abstract][Full Text] [Related]